Seragon conclui estudo pré-clínico do candidato a intervenção no envelhecimento SRN-901

Seragon Biosciences Israel Algeria Bahrain Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Qatar Saudi Arabia Syria Tunisia United Arab Emirates Yemen Angola Botswana Ethiopia Gambia Ghana Guinea-Bissau Kenya Lesotho Liberia Malawi Maldives Mozambique Namibia Nigeria Sierra Leone Somalia South Africa Swaziland Tanzania Uganda Zambia Zimbabwe California

View original content:https://www.prnewswire.com/br/comunicados-para-a-imprensa/seragon-conclui-estudo-pre-clinico-do-candidato-a-intervencao-no-envelhecimento-srn-901-302138437.html

FONTE Seragon Biosciences